Caricamento...
The Antitumor Activity of Sodium Selenite Alone and in Combination with Gemcitabine in Pancreatic Cancer: An In Vitro and In Vivo Study
SIMPLE SUMMARY: The treatment of advanced pancreatic cancer represents a major challenge because of its chemoresistance and low survival rate. The aim of this research is to test a new antitumor agent (sodium selenite) in pancreatic cancer, both in vitro and in vivo, focusing on the molecular mechan...
Salvato in:
| Pubblicato in: | Cancers (Basel) |
|---|---|
| Autori principali: | , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
MDPI
2021
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8268835/ https://ncbi.nlm.nih.gov/pubmed/34201986 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13133169 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|